is henry meds compounded semaglutide safe Best Online Compounding Pharmacy: 5 Providers Compared (2026) Henry Meds – GLP1 Match

Patients with BMI between 27 and 29.9 may qualify when a weight-related condition is documented

Semaglutide 2.4 mg (Wegovy) has shown robust weight loss in primary obesity trials, with mean weight reductions of 14.9% in the STEP 1 trial published in the New England Journal of Medicine (2021)

Common doses are 200 to 500 micrograms once or twice a day, for 2 to 6 weeks

In the phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023), participants receiving higher doses of retatrutide achieved mean weight reductions of up to 17.5% of body weight over 24 weeks, with greater losses reported at 48 weeks